BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15299833)

  • 21. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
    Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
    Oikonomakos NG; Tiraidis C; Leonidas DD; Zographos SE; Kristiansen M; Jessen CU; Nørskov-Lauritsen L; Agius L
    J Med Chem; 2006 Sep; 49(19):5687-701. PubMed ID: 16970395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
    Oikonomakos NG; Kontou M; Zographos SE; Watson KA; Johnson LN; Bichard CJ; Fleet GW; Acharya KR
    Protein Sci; 1995 Dec; 4(12):2469-77. PubMed ID: 8580837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors.
    Benltifa M; Hayes JM; Vidal S; Gueyrard D; Goekjian PG; Praly JP; Kizilis G; Tiraidis C; Alexacou KM; Chrysina ED; Zographos SE; Leonidas DD; Archontis G; Oikonomakos NG
    Bioorg Med Chem; 2009 Oct; 17(20):7368-80. PubMed ID: 19781947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.
    Oikonomakos NG; Zographos SE; Tsitsanou KE; Johnson LN; Acharya KR
    Protein Sci; 1996 Dec; 5(12):2416-28. PubMed ID: 8976550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme kinetics of muscle glycogen phosphorylase b.
    Walcott S; Lehman SL
    Biochemistry; 2007 Oct; 46(42):11957-68. PubMed ID: 17910419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.
    Kosmopoulou MN; Leonidas DD; Chrysina ED; Bischler N; Eisenbrand G; Sakarellos CE; Pauptit R; Oikonomakos NG
    Eur J Biochem; 2004 Jun; 271(11):2280-90. PubMed ID: 15153119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure-based design: formalism and application of receptor-dependent RD-4D-QSAR analysis to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(5):1591-607. PubMed ID: 14502494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b.
    Cruciani G; Watson KA
    J Med Chem; 1994 Aug; 37(16):2589-601. PubMed ID: 8057302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
    Anderka O; Loenze P; Klabunde T; Dreyer MK; Defossa E; Wendt KU; Schmoll D
    Biochemistry; 2008 Apr; 47(16):4683-91. PubMed ID: 18373353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
    Pinotsis N; Leonidas DD; Chrysina ED; Oikonomakos NG; Mavridis IM
    Protein Sci; 2003 Sep; 12(9):1914-24. PubMed ID: 12930991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.
    Gregoriou M; Noble ME; Watson KA; Garman EF; Krulle TM; de la Fuente C; Fleet GW; Oikonomakos NG; Johnson LN
    Protein Sci; 1998 Apr; 7(4):915-27. PubMed ID: 9568898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Kosmopoulou M; Zographos SE; Leonidas DD; Chrysina ED; Somsák L; Nagy V; Praly JP; Docsa T; Tóth B; Gergely P
    Eur J Biochem; 2002 Mar; 269(6):1684-96. PubMed ID: 11895439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis and modelling of the allosteric behaviour of liver and muscle glycogen phosphorylases.
    Cuadri-Tomé C; Barón C; Jara-Pérez V; Parody-Morreale A; Martinez JC; Cámara-Artigas A
    J Mol Recognit; 2006; 19(5):451-7. PubMed ID: 16691548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase B.
    Oikonomakos NG; Skamnaki VT; Osz E; Szilágyi L; Somsák L; Docsa T; Tóth B; Gergely P
    Bioorg Med Chem; 2002 Feb; 10(2):261-8. PubMed ID: 11741774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
    Andersen B; Westergaard N
    Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CoMFA and docking studies on glycogen phosphorylase a inhibitors as antidiabetic agents.
    Prathipati P; Pandey G; Saxena AK
    J Chem Inf Model; 2005; 45(1):136-45. PubMed ID: 15667139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes.
    Martin JL; Veluraja K; Ross K; Johnson LN; Fleet GW; Ramsden NG; Bruce I; Orchard MG; Oikonomakos NG; Papageorgiou AC
    Biochemistry; 1991 Oct; 30(42):10101-16. PubMed ID: 1931942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes.
    Board M; Bollen M; Stalmans W; Kim Y; Fleet GW; Johnson LN
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):845-52. PubMed ID: 7487940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.
    Rath VL; Ammirati M; LeMotte PK; Fennell KF; Mansour MN; Danley DE; Hynes TR; Schulte GK; Wasilko DJ; Pandit J
    Mol Cell; 2000 Jul; 6(1):139-48. PubMed ID: 10949035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.